AgeX Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.05.20	AgeX Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update (Businesswire)
01.05.20	AgeX Therapeutics Announces Reduction in Projected Cash Expenditures (Businesswire)
30.03.20	AgeX Therapeutics Reports Fourth Quarter and Annual 2019 Financial Results and Provides Business Update (Businesswire)
20.03.20	AgeX Therapeutics Licensee ImStem Biotechnology Announces FDA has Lifted the Hold and Cleared the Investigational New Drug Application for IMS001 for the Treatment of Multiple Sclerosis (Businesswire)
28.02.20	AgeX Therapeutics Researchers Publish Paper on the Age Reprogramming of Super-Centenarian Cells (Businesswire)
03.02.20	AgeX Therapeutics to Collaborate with University of California, Irvine on Neural Stem Cell Research Program for Huntington’s Disease and Other Neurological Disorders (Businesswire)
29.01.20	AgeX Therapeutics Enters Research Collaboration With Japanese Biopharma Company to Generate Hypoimmunogenic Cells (Businesswire)
14.01.20	AgeX Therapeutics to Participate at Four Conferences in January 2020 (Businesswire)
26.12.19	AgeX Therapeutics Announces Drawdown of Second Tranche of Loan Facility from Juvenescence Ltd. (Businesswire)
10.12.19	AgeX Therapeutics and Lineage Cell Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells (Businesswire)
09.12.19	AgeX Issues Letter To Shareholders - Quick Facts (RTTNews)
09.12.19	AgeX Therapeutics Issues Year-End Letter to Shareholders (Businesswire)
14.11.19	AgeX Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update (Businesswire)
09.11.19	AgeX Therapeutics to Present at Investing in the Age of Longevity Conference (Businesswire)
30.10.19	AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance UniverCyteTM Technology Platform (Businesswire)
11.10.19	AgeX Therapeutics to Present at Metabesity 2019 (Businesswire)
08.10.19	Today's Top 5 Gainers In Healthcare Sector (AKCA, PFNX, LVGO…) (RTTNews)
04.09.19	AgeX Therapeutics Publishes Theoretical Basis of Human Cell Age-Reversal in the Journal Regenerative Medicine (Businesswire)
14.08.19	5 Top Gainers In Healthcare Sector (DCPH, MBIO, BCEL...) (RTTNews)
05.08.19	Regenerative Medicine Leader Michael H. May Joins AgeX Board of Directors (Businesswire)
19.06.19	5 Top Gainers In Healthcare Sector (GTHX, AGE, OVID...) (RTTNews)
15.05.19	AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update (Businesswire)
01.05.19	AgeX Therapeutics to Participate at Biotech Investing in Longevity from Aikora Health and Foresight Institute (Businesswire)
05.04.19	AgeX Therapeutics to Present at Master Investor Show 2019 (Businesswire)
01.04.19	AgeX Therapeutics Reports Fourth Quarter and Annual 2018 Financial Results and Provides Business Update (Businesswire)
22.03.19	AgeX Therapeutics Receives $4.5 Million From Exercise of Warrants (Businesswire)
21.03.19	AgeX Therapeutics to Present at Undoing Aging 2019, March 28-30 in Berlin, Germany (Businesswire)
07.03.19	LifeMap Sciences and iCarbonX Research Shenzhen Announce Strategic Collaboration (Businesswire)
20.02.19	6 Top Gainers In Healthcare Sector (ORPN, INSY, AGE...) (RTTNews)
31.01.19	AgeX Therapeutics to Present at Longevity Leaders Conference, February 4 in London (Businesswire)
22.01.19	AgeX Therapeutics’ CEO Dr. Michael D. West Presents at Precision Medicine World Conference 2019 (Businesswire)
11.01.19	6 Top Gainers In Healthcare Sector (PLXP, AMRN, MRTX...) (RTTNews)
10.01.19	LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic Partnership to Offer Leading Clinical NGS Solution to the China Market (Businesswire)
09.01.19	AgeX Therapeutics Publishes Data in Peer-Reviewed Journal to Advance Potential Cell Therapy AgeX-BAT1 for Type II Diabetes and Obesity (Businesswire)
02.01.19	AgeX Therapeutics to Present at Biotech Showcase 2019 (Businesswire)
13.04.05	A.G. Edwards' New National Branding Effort Brings Personal Savings ' (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Holcim	91.22	1.56 %	K V
Sonova Hldg	319.70	1.56 %	K V
Lonza Grp	591.00	1.34 %	K V
Sika	231.50	1.27 %	K V
CieFinRichemont	171.70	0.94 %	K V
Swiss Re	138.05	-0.40 %	K V
Zurich Insur Gr	537.20	-0.52 %	K V
Kuehne+Nagel Int	204.60	-0.97 %	K V
Part Grp Hldg	1’389.50	-1.03 %	K V
Givaudan	3’818.00	-3.12 %	K V

Nachrichten zu AgeX Therapeutics Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten